COLAS & ASSOCIATES, LLC

Filings
11
Clients
2
Total Income
$150,000
Years Active
2024–2024

Filings

Year Client Period Income Expenses Doc
2024 TEVA PHARMACEUTICALS USA, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$10,000
2024 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$10,000
2024 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 3rd Quarter (July 1 - Sep 30)
AMENDED
$20,000
2024 TEVA PHARMACEUTICALS USA, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$40,000
2024 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$20,000
2024 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$20,000
2024 TEVA PHARMACEUTICALS USA, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$10,000
2024 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$40,000
2024 TEVA PHARMACEUTICALS USA, INC. 2nd Quarter (Apr 1 - June 30)
Registration
2024 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$20,000
Page 1 of 2  ·  11 filings Next

Clients Represented

ClientFilingsTotal Income
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 7 $90,000
TEVA PHARMACEUTICALS USA, INC. 4 $60,000

Lobbyists

NameDisclosed Prior Position
BRIAN COLAS Sen. Cotton, Dep. Chief of Staff/General Counsel; US Senate Judiciary Comm., Counsel; Senate Banking Comm., Econ. Polic…